Process
10th Edition
• Author(s)Linda Lane Lilley;
Shelly Rainforth Collins; Julie
S. Snyder
QUESTION 1
Item Type: MCQ
Clinical Scenario:
A nursing student is reviewing the FDA pregnancy risk
categories prior to administering medications to a 28-year-old
,female patient who has just discovered she is 6 weeks pregnant.
The patient has a history of asthma and requires daily
medication management.
Question Stem:
The nursing instructor asks the student to identify which drug
category indicates the highest risk for fetal harm based on the
historical FDA pregnancy risk classification system. Which
response by the student demonstrates correct understanding?
Answer Options:
A. Category A - Controlled studies show no risk
B. Category B - No evidence of risk in humans
C. Category C - Risk cannot be ruled out
D. Category X - Contraindicated in pregnancy
Correct Answer: D
Comprehensive Rationale:
Category X medications have demonstrated fetal abnormalities
in animal and/or human studies and the risks clearly outweigh
any potential therapeutic benefit. These medications are
contraindicated in women who are or may become pregnant.
Examples include isotretinoin for acne, thalidomide, and certain
statins. The historical FDA pregnancy categories (A, B, C, D, X)
provided a framework for understanding teratogenic risk,
though they have been replaced by the Pregnancy and
Lactation Labeling Rule (PLLR) which provides more detailed
,information. Understanding these categories is essential for
nurses to ensure medication safety during pregnancy and to
provide appropriate patient education about potential risks.
Distractor Analysis:
• Option A (Category A): INCORRECT. Category A
medications have demonstrated no risk to the fetus in
controlled human studies. This represents the LOWEST risk
category, not the highest. A common misconception is that
all prescription medications carry significant fetal risk, but
many vitamins and some medications fall into Category A.
• Option B (Category B): INCORRECT. Category B indicates
animal reproduction studies have failed to demonstrate a
risk to the fetus but adequate human studies are lacking.
While caution is warranted, this represents a lower risk
category compared to Categories C, D, and X. Clinical
misconception: Students often confuse Category B with
"safe" when it actually indicates limited human data.
• Option C (Category C): INCORRECT. Category C
medications have shown adverse effects in animal studies,
but there are no adequate human studies. The potential
benefits may warrant use despite potential risks. This
represents moderate risk but is not the highest risk
category. Safety risk: Clinicians may prescribe these when
benefits outweigh risks, but careful monitoring is required.
, Nursing Process Integration:
• Primary Component: Assessment - The nurse must assess
pregnancy status, reproductive potential, and teratogenic
risk before medication administration.
• Planning: Developing strategies to avoid Category X
medications in pregnant patients and identifying safer
alternatives.
• Implementation: Verifying pregnancy status, providing
education about medication risks during pregnancy, and
consulting with healthcare providers about medication
selection.
Clinical Judgment Measurement Model (NCJMM):
• Recognize Cues: Identify pregnancy risk categories and
their implications
• Analyze Cues: Interpret the meaning of different FDA
categories
• Prioritize Hypotheses: Recognize Category X as
representing the highest teratogenic risk
• Generate Solutions: Select appropriate medications based
on pregnancy status
Difficulty Level: Easy
Bloom's Cognitive Level: Remember